Clinical Trials
PhaseBio begins Phase I hypertension study with Vasomera
PhaseBio Pharmaceuticals, a biotechnology company, has initiated Phase I clinical study with its novel compound, Vasomera (PB1046), in patients with Stage 1 and 2...
Clinical Trials
TxCell reports positive immuno-monitoring results from Phase I/II Crohn’s...
TxCell SA, a biotechnology company, has announced positive immuno-monitoring results of the Phase I/II study in Crohn's disease with Ovasave. ...
Clinical Trials
Galena initiates Phase III PRESENT trial for NeuVax
Galena Biopharma has initiated Phase III trial for NeuVax (E75 peptide plus GM-CSF) vaccine in HER2 1+ and 2+ breast cancer patients in the...
Clinical Trials
Genta reports Tesetaxel Phase 2b trial data
Genta's Tesetaxel has demonstrated efficacy in the Phase 2b, confirmatory clinical trial, designed to evaluate the drug in patients with advanced gastric cancer. ...
Clinical Trials
Sanofi and Regeneron Report Positive Preliminary Phase 2 Program...
Sanofi and Regeneron Pharmaceuticals, Inc. announced positive preliminary results from the Phase 2 study program in which patients with elevated low-density lipoprotein cholesterol (LDL-C) were...
Clinical Trials
TxCell presents final positive results of the phase I/II...
TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical needs, announces today the...
Clinical Trials
First results from ongoing Phase III trial show malaria...
First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.